Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Lancet [Lancet] NLMUID: 2985213R"" wg kryterium: JN


Tytuł :
Contrast-associated acute kidney injury in a patient with lower respiratory tract infection.
Autorzy :
Cichowitz C; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. Electronic address: .
Fenves AZ; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2021 Jul 24; Vol. 398 (10297), pp. 340.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Past and present women pioneers in biomedical science.
Autorzy :
Marks L; Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK. Electronic address: .
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2021 Jul 24; Vol. 398 (10297), pp. 293-295.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Heterogeneity of treatment effects in malignant pleural mesothelioma.
Autorzy :
Di Maio M; Department of Oncology, University of Turin, Division of Medical Oncology, Ordine Mauriziano Hospital, Torino 10128, Italy. Electronic address: .
Tagliamento M; Department of Oncology, University of Genova, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2021 Jul 24; Vol. 398 (10297), pp. 301-302.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't; Comment
MeSH Terms :
Mesothelioma*/drug therapy
Mesothelioma, Malignant*
Pleural Neoplasms*/drug therapy
Humans
Raport
Tytuł :
Tocilizumab in COVID-19 therapy: who benefits, and how?
Autorzy :
Neumann AU; Department of Environmental Medicine, Faculty of Medicine, Universitätsklinikum Augsburg, Augsburg, Germany; Institute of Environmental Medicine, Helmholtz Center Munich, Augsburg, Germany. Electronic address: .
Goekkaya M; Department of Environmental Medicine, Faculty of Medicine, Universitätsklinikum Augsburg, Augsburg, Germany; Environmental Medicine, Technical University Munich, Munich, Germany.
Dorgham K; Sorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses, Paris, France.
Traidl-Hoffmann C; Department of Environmental Medicine, Faculty of Medicine, Universitätsklinikum Augsburg, Augsburg, Germany; Institute of Environmental Medicine, Helmholtz Center Munich, Augsburg, Germany; Environmental Medicine, Technical University Munich, Munich, Germany.
Gorochov G; Sorbonne Université, INSERM, Centre d'Immunologie et des Maladies Infectieuses, Paris, France; Département d'Immunologie, Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, France.
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2021 Jul 24; Vol. 398 (10297), pp. 299-300.
Typ publikacji :
Letter; Comment
MeSH Terms :
COVID-19*/drug therapy
Antibodies, Monoclonal, Humanized ; Humans ; SARS-CoV-2
SCR Protocol :
COVID-19 drug treatment
Opinia redakcyjna
Tytuł :
The nutrition agenda must include tobacco control - Authors' reply.
Autorzy :
Victora CG; International Center for Equity in Health, Federal University of Pelotas, Pelotas 96020-220, Brazil. Electronic address: .
Black RE; Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Bhutta Z; Centre for Global Child Health, The Hospital for Sick Children, Toronto, ON, Canada.
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2021 Jul 24; Vol. 398 (10297), pp. 301.
Typ publikacji :
Letter; Comment
MeSH Terms :
Tobacco*
Tobacco Products*
Humans ; Nutritional Status ; Tobacco Use
Opinia redakcyjna
Tytuł :
The nutrition agenda must include tobacco control.
Autorzy :
Klein JD; Department of Pediatrics, University of Illinois at Chicago, Chicago, IL 60612, USA. Electronic address: .
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2021 Jul 24; Vol. 398 (10297), pp. 300-301.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
Raport
Tytuł :
Tocilizumab in COVID-19 therapy: who benefits, and how? - Authors' reply.
Autorzy :
Horby P; Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK. Electronic address: .
Staplin N; Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.
Haynes R; Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.
Landray M; Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2021 Jul 24; Vol. 398 (10297), pp. 300.
Typ publikacji :
Letter; Comment
MeSH Terms :
COVID-19*/drug therapy
Antibodies, Monoclonal, Humanized ; Humans ; SARS-CoV-2
SCR Protocol :
COVID-19 drug treatment
Opinia redakcyjna
Tytuł :
Heterogeneity of treatment effects in malignant pleural mesothelioma - Authors' reply.
Autorzy :
Baas P; Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands. Electronic address: .
Scherpereel A; Pulmonary and Thoracic Oncology, University of Lille, CHU Lille, INSERM U1189, Lille, France.
Nowak AK; Medical School, University of Western Australia, Perth, WA, Australia.
Oukessou A; Bristol Myers Squibb, Princeton, NJ, USA.
Zalcman G; Bichat-Claude Bernard University Hospital, Université de Paris, Paris, France.
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2021 Jul 24; Vol. 398 (10297), pp. 302.
Typ publikacji :
Letter; Comment
MeSH Terms :
Mesothelioma*/drug therapy
Mesothelioma, Malignant*
Pleural Neoplasms*/drug therapy
Humans
Opinia redakcyjna
Tytuł :
Tocilizumab in COVID-19 therapy: who benefits, and how?
Autorzy :
Yang C; Latner Thoracic Surgery Research Laboratories, Toronto General Hospital Research Institute, University Health Network, University of Toronto, Toronto, ON M5G 1L7, Canada. Electronic address: .
Zhao H; Faculty of Medicine, McGill University, Montreal, QC, Canada.
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2021 Jul 24; Vol. 398 (10297), pp. 299.
Typ publikacji :
Letter; Comment
MeSH Terms :
COVID-19*/drug therapy
Antibodies, Monoclonal, Humanized ; Humans ; SARS-CoV-2
SCR Protocol :
COVID-19 drug treatment
Opinia redakcyjna
Tytuł :
Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study.
Corporate Authors :
Global PaedSurg Research Collaboration
Źródło :
Lancet (London, England) [Lancet] 2021 Jul 24; Vol. 398 (10297), pp. 325-339. Date of Electronic Publication: 2021 Jul 13.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Antibody response after second BNT162b2 dose in allogeneic HSCT recipients.
Autorzy :
Redjoul R; Hopital Henri Mondor, 94000 Créteil, France.
Le Bouter A; Hopital Henri Mondor, 94000 Créteil, France.
Beckerich F; Hopital Henri Mondor, 94000 Créteil, France.
Fourati S; Hopital Henri Mondor, 94000 Créteil, France.
Maury S; Hopital Henri Mondor, 94000 Créteil, France. Electronic address: .
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2021 Jul 24; Vol. 398 (10297), pp. 298-299. Date of Electronic Publication: 2021 Jul 13.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
Mass infection is not an option: we must do more to protect our young.
Autorzy :
Gurdasani D; William Harvey Research Institute, Queen Mary University of London, London E1 4NS, UK. Electronic address: .
Drury J; University of Sussex, Brighton, UK.
Greenhalgh T; University of Oxford, Oxford, UK.
Griffin S; University of Leeds, Leeds, UK.
Haque Z; London, UK.
Hyde Z; University of Western Australia, Crawley, WA, Australia.
Katzourakis A; University of Oxford, Oxford, UK.
McKee M; London School of Hygiene & Tropical Medicine, London, UK.
Michie S; University College London, London, UK.
Pagel C; University College London, London, UK.
Reicher S; University of St Andrews, St Andrews, UK.
Roberts A; University of Birmingham, Birmingham, UK.
West R; University College London, London, UK.
Yates C; University of Bath, Bath, UK.
Ziauddeen H; University of Cambridge, Cambridge, UK.
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2021 Jul 24; Vol. 398 (10297), pp. 297-298. Date of Electronic Publication: 2021 Jul 07.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
Raport
Tytuł :
Physical punishment and child outcomes: a narrative review of prospective studies.
Autorzy :
Heilmann A; Department of Epidemiology and Public Health, University College London, London, UK. Electronic address: .
Mehay A; Department of Epidemiology and Public Health, University College London, London, UK.
Watt RG; Department of Epidemiology and Public Health, University College London, London, UK.
Kelly Y; Department of Epidemiology and Public Health, University College London, London, UK.
Durrant JE; Department of Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
van Turnhout J; Royal College of Physicians of Ireland, Faculty of Paediatrics, Dublin, Ireland.
Gershoff ET; Population Research Center and Department of Human Development and Family Sciences, University of Texas at Austin, Austin, TX, USA.
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2021 Jul 24; Vol. 398 (10297), pp. 355-364. Date of Electronic Publication: 2021 Jun 28.
Typ publikacji :
Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study.
Autorzy :
Berdeja JG; Sarah Cannon Research Institute, Nashville, TN, USA.
Madduri D; Mount Sinai Medical Center, New York, NY, USA.
Usmani SZ; Levine Cancer Institute-Atrium Health, Charlotte, NC, USA.
Jakubowiak A; University of Chicago Medical Center, Chicago, IL, USA.
Agha M; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
Cohen AD; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
Stewart AK; University Health Network and the Princess Margaret Cancer Centre, Toronto, ON, Canada.
Hari P; Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Htut M; City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
Lesokhin A; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Deol A; Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.
Munshi NC; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
O'Donnell E; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Avigan D; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Singh I; Janssen Research and Development, Spring House, PA, USA.
Zudaire E; Janssen Research and Development, Spring House, PA, USA.
Yeh TM; Janssen Research and Development, Raritan, NJ, USA.
Allred AJ; Janssen Research and Development, Spring House, PA, USA.
Olyslager Y; Janssen Research and Development, Beerse, Belgium.
Banerjee A; Janssen Research and Development, Spring House, PA, USA.
Jackson CC; Janssen Research and Development, Raritan, NJ, USA.
Goldberg JD; Janssen Research and Development, Raritan, NJ, USA.
Schecter JM; Janssen Research and Development, Raritan, NJ, USA.
Deraedt W; Janssen Research and Development, Beerse, Belgium.
Zhuang SH; Janssen Research and Development, Raritan, NJ, USA.
Infante J; Janssen Research and Development, Raritan, NJ, USA.
Geng D; Legend Biotech USA, Piscataway, NJ, USA.
Wu X; Legend Biotech USA, Piscataway, NJ, USA.
Carrasco-Alfonso MJ; Legend Biotech USA, Piscataway, NJ, USA.
Akram M; Legend Biotech USA, Piscataway, NJ, USA.
Hossain F; Legend Biotech USA, Piscataway, NJ, USA.
Rizvi S; Legend Biotech USA, Piscataway, NJ, USA.
Fan F; Nanjing Legend Biotechnology, Nanjing, China.
Lin Y; Mayo Clinic, Rochester, MN, USA.
Martin T; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
Jagannath S; Mount Sinai Medical Center, New York, NY, USA. Electronic address: .
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2021 Jul 24; Vol. 398 (10297), pp. 314-324. Date of Electronic Publication: 2021 Jun 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial.
Autorzy :
Chen YP; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Liu X; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Zhou Q; Department of Oncology, Xiangya Hospital, Central South University, Changsha, China.
Yang KY; Department of Oncology, Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Jin F; Department of Oncology, Affiliated Hospital of Guizhou Medical University, Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China.
Zhu XD; Department of Radiation Oncology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China; Department of Oncology, Affiliated Wuming Hospital of Guangxi Medical University, Nanning, China.
Shi M; Department of Radiation Oncology, the First Affiliated Hospital Of Air Force Medical University, Xi'an, China.
Hu GQ; Department of Oncology, Cancer Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Hu WH; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Sun Y; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Wu HF; Department of Radiation Oncology, Jilin Cancer Hospital, Changchun, China.
Wu H; Department of Radiation Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
Lin Q; Department of Radiation Oncology, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, Xiamen, China.
Wang H; Department of Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Tian Y; Department of Radiation Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Zhang N; Department of Radiation Oncology, The First People's Hospital of Foshan, Foshan, China.
Wang XC; Department of Radiation Oncology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.
Shen LF; Department of Oncology, Xiangya Hospital, Central South University, Changsha, China.
Liu ZZ; Department of Oncology, Xiangya Hospital, Central South University, Changsha, China.
Huang J; Department of Oncology, Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Luo XL; Department of Oncology, Affiliated Hospital of Guizhou Medical University, Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China.
Li L; Department of Radiation Oncology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
Zang J; Department of Radiation Oncology, the First Affiliated Hospital Of Air Force Medical University, Xi'an, China.
Mei Q; Department of Oncology, Cancer Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zheng BM; Department of Radiation Oncology, Peking University Cancer Hospital, Beijing, China.
Yue D; Department of Radiation Oncology, Jilin Cancer Hospital, Changchun, China.
Xu J; Department of Radiation Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
Wu SG; Department of Radiation Oncology, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, Xiamen, China.
Shi YX; Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Mao YP; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Chen L; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Li WF; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Zhou GQ; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Sun R; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Guo R; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Zhang Y; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Xu C; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Lv JW; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Guo Y; Clinical Trials Center, Sun Yat-sen University Cancer Center, Guangzhou, China.
Feng HX; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Tang LL; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Xie FY; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.
Sun Y; Department of Radiation Oncology, Peking University Cancer Hospital, Beijing, China.
Ma J; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China. Electronic address: .
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2021 Jul 24; Vol. 398 (10297), pp. 303-313. Date of Electronic Publication: 2021 Jun 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Pre-eclampsia.
Autorzy :
Chappell LC; Department of Women and Children's Health, School of Life Course Sciences, Kings' College London, London, UK. Electronic address: .
Cluver CA; Department of Obstetrics and Gynaecology, Stellenbosch University, Stellenbosch, South Africa; Tygerberg Hospital, Cape Town, South Africa.
Kingdom J; Department of Obstetrics and Gynaecology, University of Toronto, Toronto, ON, Canada.
Tong S; Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, VIC, Australia; Mercy Hospital for Women, Heidelberg, VIC, Australia.
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2021 Jul 24; Vol. 398 (10297), pp. 341-354. Date of Electronic Publication: 2021 May 27.
Typ publikacji :
Journal Article; Review; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Five priorities for universal COVID-19 vaccination.
Autorzy :
Abecassis A; Paris Peace Forum, 75015 Paris, France. Electronic address: .
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2021 Jul 24; Vol. 398 (10297), pp. 285-286. Date of Electronic Publication: 2021 Jun 18.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Adjuvant metronomic chemotherapy for locoregionally advanced nasopharyngeal carcinoma.
Autorzy :
Kerbel RS; Department of Medical Biophysics, Biological Sciences Platform, Sunnybrook Research Institute, University of Toronto, Toronto, ON M4N 3M5, Canada. Electronic address: .
Andre N; Metronomic Global Health Initiative, Children Hospital of La Timone, AP-HM, Aix Marseille Université, Marseille, France.
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2021 Jul 24; Vol. 398 (10297), pp. 278-279. Date of Electronic Publication: 2021 Jun 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Comment
MeSH Terms :
Nasopharyngeal Neoplasms*/drug therapy
Chemotherapy, Adjuvant ; Humans ; Nasopharyngeal Carcinoma/drug therapy
Czasopismo naukowe
Tytuł :
Participation of people living with disabilities in physical activity: a global perspective.
Autorzy :
Martin Ginis KA; Department of Medicine and Centre for Chronic Disease Prevention and Management and International Collaboration on Repair Discoveries, Faculty of Medicine, School of Health and Exercise Sciences, Faculty of Health and Social Development, and Reichwald Health Sciences Centre, University of British Columbia, Kelowna, BC, Canada. Electronic address: .
van der Ploeg HP; Department of Public and Occupational Health and Amsterdam Public Health Research Institute, Amsterdam UMC Vrije Universiteit Amsterdam, Amsterdam, Netherlands; Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.
Foster C; Centre for Exercise, Nutrition and Health Sciences, School for Policy Studies, University of Bristol, Bristol, UK.
Lai B; Division of Pediatric Rehabilitation Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
McBride CB; Spinal Cord Injury British Columbia, Vancouver, BC, Canada.
Ng K; School of Educational Sciences and Psychology, University of Eastern Finland, Joensuu, Finland; Department of Physical Education and Sport Sciences, University of Limerick, Limerick, Ireland.
Pratt M; Institute for Public Health and Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, San Diego, CA, USA.
Shirazipour CH; Research Center for Health Equity, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Smith B; School of Sport and Exercise Sciences, Durham University, Durham, UK.
Vásquez PM; Department of Family Medicine and Public Health, University of California San Diego, San Diego, CA, USA.
Heath GW; Department of Health and Human Performance, University of Tennessee at Chattanooga, Chattanooga, TN, USA.
Pokaż więcej
Źródło :
Lancet (London, England) [Lancet] 2021 Jul 21. Date of Electronic Publication: 2021 Jul 21.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies